These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24530939)

  • 1. Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy.
    Vicente-Dueñas C; Hauer J; Ruiz-Roca L; Ingenhag D; Rodríguez-Meira A; Auer F; Borkhardt A; Sánchez-García I
    Semin Cancer Biol; 2015 Jun; 32():3-9. PubMed ID: 24530939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer as a reprogramming-like disease: implications in tumor development and treatment.
    Castellanos A; Vicente-Dueñas C; Campos-Sánchez E; Cruz JJ; García-Criado FJ; García-Cenador MB; Lazo PA; Pérez-Losada J; Sánchez-García I
    Semin Cancer Biol; 2010 Apr; 20(2):93-7. PubMed ID: 20188174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How tumour cell identity is established?
    Sánchez-García I
    Semin Cancer Biol; 2015 Jun; 32():1-2. PubMed ID: 25931389
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status in cancer cell reprogramming and its clinical implications.
    Izgi K; Canatan H; Iskender B
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular reprogramming in skin cancer.
    Song IY; Balmain A
    Semin Cancer Biol; 2015 Jun; 32():32-9. PubMed ID: 24721247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Priming in Cancer Initiation.
    Vicente-Dueñas C; Hauer J; Cobaleda C; Borkhardt A; Sánchez-García I
    Trends Cancer; 2018 Jun; 4(6):408-417. PubMed ID: 29860985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Making of Leukemia.
    González-Herrero I; Rodríguez-Hernández G; Luengas-Martínez A; Isidro-Hernández M; Jiménez R; García-Cenador MB; García-Criado FJ; Sánchez-García I; Vicente-Dueñas C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of oncogenes in cancer development: a changing paradigm.
    Vicente-Dueñas C; Romero-Camarero I; Cobaleda C; Sánchez-García I
    EMBO J; 2013 May; 32(11):1502-13. PubMed ID: 23632857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early epigenetic cancer decisions.
    Martín-Lorenzo A; Gonzalez-Herrero I; Rodríguez-Hernández G; García-Ramírez I; Vicente-Dueñas C; Sánchez-García I
    Biol Chem; 2014 Nov; 395(11):1315-20. PubMed ID: 25205718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology.
    Laplane L; Beke A; Vainchenker W; Solary E
    Stem Cells; 2015 Oct; 33(10):2887-92. PubMed ID: 26179060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Generation of Leukemic Stem Cells by HSC Targeting by Transgenesis.
    Vicente-Dueñas C
    Methods Mol Biol; 2021; 2185():361-372. PubMed ID: 33165860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological cellular reprogramming and cancer.
    Abollo-Jiménez F; Jiménez R; Cobaleda C
    Semin Cancer Biol; 2010 Apr; 20(2):98-106. PubMed ID: 20188173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of mesenchymal stem cells by oncogenes.
    Eid JE; Garcia CB
    Semin Cancer Biol; 2015 Jun; 32():18-31. PubMed ID: 24938913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cell technology for dissecting the cancer epigenome.
    Semi K; Yamada Y
    Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
    Felsher DW
    Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?
    Yilmazer A; de Lázaro I; Taheri H
    Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Cellular Identity in Cancer.
    Roy N; Hebrok M
    Dev Cell; 2015 Dec; 35(6):674-84. PubMed ID: 26702828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Pliancy and the Multistep Process of Tumorigenesis.
    Puisieux A; Pommier RM; Morel AP; Lavial F
    Cancer Cell; 2018 Feb; 33(2):164-172. PubMed ID: 29438693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roots and stems: stem cells in cancer.
    Polyak K; Hahn WC
    Nat Med; 2006 Mar; 12(3):296-300. PubMed ID: 16520777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.